Compare IXHL & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | IXHL | NXN |
|---|---|---|
| Founded | 2001 | 1992 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 47.3M |
| IPO Year | N/A | N/A |
| Metric | IXHL | NXN |
|---|---|---|
| Price | $0.39 | $12.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 24.9M | 9.7K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | ★ $12,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $48.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.08 | $10.64 |
| 52 Week High | $2.25 | $12.45 |
| Indicator | IXHL | NXN |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 42.07 |
| Support Level | $0.38 | $11.90 |
| Resistance Level | $0.45 | $12.18 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 39.16 | 35.75 |
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.